|Podcasts|December 9, 2022
Achieving Success in the Rare Disease Space
Author(s)Nicholas Saraceno, Editor
Lessons learned around commercializing new products in this niche sector
Advertisement
Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply
2
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
3
